<p>¡Hola Fupas! In this episode, your beloved fatties discuss the one, the only: Semaglutide!!! We take on the ‘Ozempic Revolution’ and take some turns into a heated discussion about ‘movement strategy’ to ponder a pressing question: <em>What the hell are fat activists even asking for?</em> But before any of that, we discuss our respective fast food sweet treats. It’s a packed episode, so grab a snack and prepare to be rage with us!<span class= "Apple-converted-space">&nbsp;</span></p> <p>(P.S. We recorded this months ago before we got our audio sorted out. Sorry for any hiccups!)<span class= "Apple-converted-space">&nbsp;</span></p> <p>&nbsp;</p> <p><span class="Apple-converted-space">Media mentioned:</span></p> <p><a href="https://www.marquiselemercedes.com/read/wegovy">Wegovy Isn’t a Game Changer, But An Update by Marquisele Mercedes</a></p> <p><a href= "https://soundcloud.com/deathpanel/institutional-antifatness-w-marquisele-mercedes-monica-kriete-020223?utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing"> Institutional Antifatness w/ Marquisele Mercedes & Monica Kriete (from the Death Panel podcast)</a></p> <p><a href= "https://amp.theguardian.com/business/2023/mar/16/novo-nordisk-firm-behind-wegovy-slimming-jab-suspended-from-uk-trade-association"> "Firm behind Wegovy slimming jab suspended from UK trade association"</a>&nbsp;</p> <p><a href= "https://www.theguardian.com/society/2023/mar/12/orchestrated-pr-campaign-how-skinny-jab-drug-firm-sought-to-shape-obesity-debate"> ‘Orchestrated PR campaign’: how skinny jab drug firm sought to shape obesity debate</a>&nbsp;</p> <p><a href= "https://weightandhealthcare.substack.com/p/wegovys-so-called-long-term-study"> Wegovy’s So-Called “Long-Term” Study by Ragen Chastain</a>&nbsp;</p> <p><a href= "https://weightandhealthcare.substack.com/p/weight-loss-intervention-research"> Weight Loss Research Should Be Five Years Long - At Least by Ragen Chastain</a>&nbsp;</p> <p><a href= "https://www.nytimes.com/2023/01/19/opinion/obesity-disease-weight-loss.html?unlocked_article_code=zAZzVXLgGZgudUsWjun-upVS4ctmvk6FG0ji7HaNeWI2if-zqXOhagWcOraN613nQUgULfJOiHhjan8gI6pMRYjlfoBi8YqnM1r6NBkpntFiuYC5sb_NNhqDOlG1BxOomqM5d8Io-rrO9nPcODdSgoac77kA67r3EeACNgOXwpl3D5ZtA4flfPM54v9kZvCjb7Gf2MUPxsm5Xf0CRKeCzWy-F8VytmyH8LQ2OOMomdZTMfqc5QVQ2eEDffG40hHJPo_rbGf7NDPRAEgcxWf6tiszKGAv2zT6UjDnwe6jwhQZuWnyMhTD1EWZJTDPu0ujUFqNPXeBOdCYv3KpI1_ByQALlCTlJQ&smid=nytcore-ios-share&referringSource=articleShare"> I Lost Weight on Ozempic. Here’s What the Debate Gets Wrong. (from the NYT’s First Person podcast)</a><span class= "Apple-converted-space">&nbsp;</span></p>